1.A Novel GFAP Mutation in Late-Onset Alexander Disease Showing Diffusion Restriction.
Tai Seung NAM ; Jeeyoung OH ; Michael LEVY ; Kyung Wook KANG ; Seok Yong CHOI ; Myeong Kyu KIM
Journal of Clinical Neurology 2017;13(4):426-428
No abstract available.
Alexander Disease*
;
Diffusion*
2.Age-dependent root canal instrumentation techniques: a comprehensive narrative review
Michael SOLOMONOV ; Hyeon-Cheol KIM ; Avi HADAD ; Dan Henry LEVY ; Joe Ben ITZHAK ; Oleg LEVINSON ; Hadas AZIZI
Restorative Dentistry & Endodontics 2020;45(2):e21-
The aim of this article was to review age-dependent clinical recommendations for appropriate root canal instrumentation techniques. A comprehensive narrative review of canal morphology, the structural characteristics of dentin, and endodontic outcomes at different ages was undertaken instead of a systematic review. An electronic literature search was carried out, including the Medline (Ovid), PubMed, and Web of Science databases. The searches used controlled vocabulary and free-text terms, as follows: ‘age-related root canal treatment,’ ‘age-related instrumentation,’ ‘age-related chemo-mechanical preparation,’ ‘age-related endodontic clinical recommendations,’ ‘root canal instrumentation at different ages,’ ‘geriatric root canal treatment,’ and ‘pediatric root canal treatment.’ Due to the lack of literature with practical age-based clinical recommendations for an appropriate root canal instrumentation technique, a narrative review was conducted to suggest a clinical algorithm for choosing the most appropriate instrumentation technique during root canal treatment. Based on the evidence found through the narrative review, an age-related clinical algorithm for choosing appropriate instrumentation during root canal treatment was proposed. Age affects the morphology of the root canal system and the structural characteristics of dentin. The clinician’s awareness of root canal morphology and dentin characteristics can influence the choice of instruments for root canal treatment.
3.Is Corticospinal Tract Degeneration Caused by Sjögren Syndrome?.
Tai Seung NAM ; Michael LEVY ; Sang Hoon KIM ; Kyung Wook KANG ; Byoung Joon KIM ; Seung Han LEE
Journal of Clinical Neurology 2018;14(2):259-260
No abstract available.
Pyramidal Tracts*
4.Primary central nervous system lymphoma with intramedullary spinal cord involvement mimicking inflammatory demyelinating disease
Hyunsoo KIM ; Tai Seung NAM ; Michael LEVY ; Kyung Hwa LEE ; Jahae KIM ; Seung Jin LEE
Journal of Neurocritical Care 2019;12(1):55-63
BACKGROUND: Spinal cord involvement of primary central nervous system lymphoma (PCNSL) is rare in a young immunocompetent patient and can be misdiagnosed as an inflammatory demyelinating disease (IDD) of the central nervous system.
Biopsy
;
Brain
;
Central Nervous System
;
Cerebrospinal Fluid
;
Cervical Cord
;
Demyelinating Diseases
;
Drug Therapy
;
Electrons
;
Hand
;
Humans
;
Leukocytosis
;
Lymphoma
;
Magnetic Resonance Imaging
;
Medulla Oblongata
;
Methotrexate
;
Middle Aged
;
Multiple Sclerosis
;
Neuromyelitis Optica
;
Spinal Cord
5.Inhibition of Neurogenic Inflammatory Pathways Associated with the Reduction in Discogenic Back Pain
Jose A. CANSECO ; Hannah A. LEVY ; Brian A. KARAMIAN ; Olivia BLABER ; Michael CHANG ; Neil PATEL ; John CURRAN ; Alan S. HILIBRAND ; Gregory D. SCHROEDER ; Alexander R. VACCARO ; Dessislava Z. MARKOVA ; David E. SURREY ; Christopher K. KEPLER
Asian Spine Journal 2023;17(6):1043-1050
Methods:
All adult patients diagnosed with spinal spondylosis and migraine treated with CGRP inhibitors at a single academic institution between 2017 and 2020 were retrospectively identified. Patient demographic and medical data, follow-up duration, migraine severity and frequency, spinal pain, functional status, and mobility before and after the administration of CGRP inhibitors were collected. Paired univariate analysis was conducted to determine significant changes in spinal pain, headache severity, and headache frequency before and after the administration of CGRP inhibitors. The correlation between changes in the spinal pain score and functional or mobility improvement was assessed with Spearman’s rho.
Results:
In total, 56 patients were included. The mean follow-up time after the administration of CGRP inhibitors was 123 days for spinal pain visits and 129 days for migraine visits. Backeck pain decreased significantly (p <0.001) from 6.30 to 4.36 after starting CGRP inhibitor therapy for migraine control. As recorded in the spine follow-up notes, 25% of patients experienced a functional improvement in the activities of daily living, and 17.5% experienced mobility improvement while taking CGRP inhibitors. Change in back/ neck pain moderately correlated (ρ=−0.430) with functional improvement but was not correlated with mobility improvement (ρ=−0.052).
Conclusions
Patients taking CGRP inhibitors for chronic migraines with comorbid degenerative spinal conditions experienced significant off-target reduction of backeck pain.